NewAmsterdam Pharma Company N.V.
NAMS
$35.26
-$0.59-1.65%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 66.29% | 71.62% | 68.03% | 145.03% | 0.97% |
| Total Receivables | 293.49% | 265.33% | -60.97% | 1,032.64% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -21.74% | 18.40% | -21.73% | 77.53% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 67.25% | 72.86% | 67.54% | 148.97% | -- |
|
|
|||||
| Total Current Assets | 67.25% | 72.86% | 67.54% | 148.97% | -- |
| Net Property, Plant & Equipment | -21.41% | -21.32% | 336.69% | 566.34% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -25.97% | -13.28% | 3.29% | 214.12% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 79.06% | 82.48% | 67.55% | 149.10% | -- |
|
|
|||||
| Total Accounts Payable | -48.40% | 11.75% | -28.69% | -71.97% | -- |
| Total Accrued Expenses | -4.56% | -7.20% | -19.55% | 19.39% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -24.58% | -3.85% | 486.05% | 310.00% | -- |
| Total Finance Division Other Current Liabilities | 89.61% | -29.29% | -35.51% | 310.49% | -- |
| Total Other Current Liabilities | 89.61% | -29.29% | -35.51% | 310.49% | -- |
| Total Current Liabilities | 41.25% | -19.41% | -31.50% | 114.28% | -- |
|
|
|||||
| Total Current Liabilities | 41.25% | -19.41% | -31.50% | 114.28% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -68.05% | -68.60% | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -3.27% | -38.20% | -46.45% | 82.47% | -- |
|
|
|||||
| Common Stock & APIC | 67.80% | 66.87% | 67.58% | 118.26% | -- |
| Retained Earnings | -47.40% | -36.85% | -45.61% | -76.22% | -- |
| Treasury Stock & Other | 4.93% | -2.15% | 0.27% | 1.02% | -- |
| Total Common Equity | 92.17% | 100.93% | 88.77% | 162.66% | -17.82% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 92.17% | 100.93% | 88.77% | 162.66% | -17.82% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 92.17% | 100.93% | 88.77% | 162.66% | -17.82% |
|
|
|||||